Source:http://linkedlifedata.com/resource/pubmed/id/15979036
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2005-6-27
|
pubmed:abstractText |
Mucopolysaccharidosis type VI (MPS VI, Maroteaux-Lamy syndrome, McKusick #253200) is a lysosomal storage disorder that is caused by a deficiency in the lysosomal exohydrolase N-acetylgalactosamine-4-sulphatase (4-sulphatase, EC 3.1.6.1). We report a patient with no obvious clinical signs of MPS VI that has 5% of normal 4-sulphatase catalytic capacity. This patient represents an index case for the attenuated end of the MPS VI clinical spectrum.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1096-7192
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
236-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15979036-Adult,
pubmed-meshheading:15979036-DNA Mutational Analysis,
pubmed-meshheading:15979036-Female,
pubmed-meshheading:15979036-Humans,
pubmed-meshheading:15979036-Lysosomes,
pubmed-meshheading:15979036-Mucopolysaccharidoses,
pubmed-meshheading:15979036-Mucopolysaccharidosis VI,
pubmed-meshheading:15979036-Mutation, Missense,
pubmed-meshheading:15979036-N-Acetylgalactosamine-4-Sulfatase
|
pubmed:year |
2005
|
pubmed:articleTitle |
An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum.
|
pubmed:affiliation |
Lysosomal Diseases Research Unit, Department of Genetic Medicine, Women's and Children's Hospital, North Adelaide, SA 5006, Australia. douglasbrooks@adelaide.edu.au
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|